Junior Bioinformatician
7 months ago
We are seeking a talented Bioinformatician to join the Spatial Profiling and Annotation Centre of Excellence (SPACE), led by Prof. Gregory Hannon and Dr. Dario Bressan, at the CRUK Cambridge Institute, University of Cambridge. This role involves analysing and integrating single-cell and spatial transcriptomic and proteomic data across various cancer types, with the goal to understand how a tumour's spatial organization influences its progression, dissemination, and response to therapy.
The Hannon group is renowned for its contributions to RNA biology and cancer research, consistently developing innovative tools to tackle cutting-edge questions. The group has established a robust pipeline for 3D spatial characterization of tumours and tissues, amassing unique imaging data paired with spatially and temporally resolved single-cell transcriptomics and proteomics. You will play a key role in analysing and interpreting this data, generating hypotheses to be tested using animal models and ex-vivo systems.
Fixed-term: The funds for this post are available for 1 years in the first instance.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
-
Targeted Protein Degradation Expert
7 days ago
Cambridge, Cambridgeshire, United Kingdom Amphista Therapeutics Limited Full timeAbout the RoleWe are looking for a highly skilled Senior Principal Computational Chemist to join our team at Amphista Therapeutics Limited. As a key domain expert for computational chemistry and biomolecular data, you will consult with scientific teams across the company.Your responsibilities will include maintaining a comprehensive awareness of contemporary...
-
Principal Computational Chemist
2 weeks ago
Cambridge, United Kingdom Amphista Therapeutics Limited Full timeAmphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential...
-
Principal Computational Chemist
1 week ago
cambridge, United Kingdom Amphista Therapeutics Limited Full timeJob Description Amphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full...
-
Principal Computational Chemist
3 weeks ago
Cambridge, United Kingdom Amphista Therapeutics Limited Full timeAmphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential...
-
Principal Computational Chemist
4 weeks ago
Cambridge, United Kingdom Amphista Therapeutics Limited Full timeAmphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential...
-
Principal Computational Chemist
3 weeks ago
Cambridge, United Kingdom Amphista Therapeutics Limited Full timeJob Description Amphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full...
-
Principal Computational Chemist
3 weeks ago
Cambridge, United Kingdom Amphista Therapeutics Limited Full timeAmphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential...
-
Principal Computational Chemist
2 weeks ago
Cambridge, Cambridgeshire, United Kingdom Amphista Therapeutics Limited Full timeAmphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential...
-
Principal Computational Chemist
2 weeks ago
Cambridge, Cambridgeshire, United Kingdom Amphista Therapeutics Limited Full timeAmphista Therapeutics is focused on transforming the lives of patients with severe diseases including cancer. The company is applying its proprietary Amphista degrader platform to advance new approaches in targeted protein degradation (TPD). They aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential...
-
Chemistry Scientist
2 weeks ago
Cambridge, Cambridgeshire, United Kingdom Amphista Therapeutics Limited Full timeThey aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential of this transformational approach. Founded by Advent Life Sciences, Amphista is a spin-out of TPD expert Professor Alessio Ciulli’s laboratories at the University of Dundee. The Company has raised over $60M to date and is funded by leading...
-
Chemistry Scientist
2 weeks ago
Cambridge, Cambridgeshire, United Kingdom Amphista Therapeutics Limited Full timeThey aim to address the challenges faced by earlier stage TPD research and to realise the full therapeutic potential of this transformational approach. Founded by Advent Life Sciences, Amphista is a spin-out of TPD expert Professor Alessio Ciulli’s laboratories at the University of Dundee. The Company has raised over $60M to date and is funded by leading...